Products & Programs PharmacyMedicare AdvantageAugust 3, 2023

Specialty pharmacy medical step therapy for hyaluronan injections

The following Part B medications from the current Clinical Criteria Guidelines are included in our medical step therapy precertification review process. Step therapy review will apply upon precertification initiation, in addition to the current medical necessity review (as is current procedure). Step therapy will not apply for members who are actively receiving medications listed below. 

There are no clinical changes to Clinical Criteria CC-005, Hyaluronan Injections. Based on feedback, the table listing the preferred and non-preferred products has been updated to present the information in a more useful manner. The updated table identifies preferred alternatives based on injection series. 

Clinical Criteria Guidelines are publicly available on the provider website. Visit the Clinical Criteria page to search for specific criteria.

Clinical UM Guidelines

Preferred drug(s)

Nonpreferred drug(s)

CC-0005

Single injection

Durolane

 

Three injection series

Euflexxa

Gel-Syn

 

Five injection series:

Supartz

 

Single injection:

Gel-One

Monovisc

Synvisc-one

 

Two injection series

Hymovis

 

Three Injection series:

Orthovisc

Synojoynt

Synvisc

Triluron

Trivisc

 

Five injection series:

Genvisc 850

Hyalgan

Visco-3

MULTI-BCBS-CR-031138-23-CPN30365

PUBLICATIONS: September 2023 Provider Newsletter